FSSNX
Price
$29.59
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
IVVIX
Price
$20.67
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
Ad is loading...

FSSNX vs IVVIX

Header iconFSSNX vs IVVIX Comparison
Open Charts FSSNX vs IVVIXBanner chart's image
Fidelity Small Cap Index
Price$29.59
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Delaware Ivy Smid Cap Core Fund
Price$20.67
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
FSSNX vs IVVIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FSSNX vs. IVVIX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSSNX is a StrongBuy and IVVIX is a Buy.

FUNDAMENTALS
Fundamentals
FSSNX has more cash in the bank: 26.9B vs. IVVIX (372M). FSSNX pays higher dividends than IVVIX: FSSNX (1.36) vs IVVIX (0.71). FSSNX was incepted earlier than IVVIX: FSSNX (13 years) vs IVVIX (18 years). IVVIX is a more actively managed with annual turnover of: 13.00 vs. FSSNX (9.00). FSSNX (0) and IVVIX (0) have matching initial minimum investment requirements. IVVIX (34.78) and FSSNX (33.68) have marching annual gain over last year. FSSNX return over 5 years is better than : 51.61 vs. IVVIX (8.20).
FSSNXIVVIXFSSNX / IVVIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years18 years-
Gain YTD18.33020.82088%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets26.9B372M7,231%
Annual Yield % from dividends1.360.71193%
Returns for 1 year33.6834.7897%
Returns for 3 years0.32-21.17-1%
Returns for 5 years51.618.20630%
Returns for 10 years93.177.201,294%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TR32.290.15
+0.47%
Tootsie Roll Industries
AU24.12-0.51
-2.07%
AngloGold Ashanti plc
CDNA22.78-0.54
-2.32%
CareDx
ATNF2.89-0.09
-3.02%
180 Life Sciences Corp
ANIX3.07-0.18
-5.54%
Anixa Biosciences